Noile-Immune Biotech Inc. (TYO:4893)
Japan
· Delayed Price · Currency is JPY 142.00
-3.00 (-2.07%)
Apr 28, 2025, 3:30 PM JST
Noile-Immune Biotech Market Cap
Noile-Immune Biotech has a market cap or net worth of 6.15 billion as of April 28, 2025. Its market cap has decreased by -22.78% in one year.
Market Cap
6.15B
Enterprise Value
1.48B
Revenue
7.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
142.00
Market Cap Chart
Since June 28, 2023, Noile-Immune Biotech's market cap has decreased from 30.89B to 6.15B, a decrease of -80.09%. That is a compound annual growth rate of -58.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 6.15B | -16.47% |
| Dec 30, 2024 | 7.36B | -19.77% |
| Dec 29, 2023 | 9.17B | -70.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 13.62T |
| Daiichi Sankyo Company | 6,561.88B |
| Takeda Pharmaceutical Company | 6,512.32B |
| HOYA Corporation | 5,670.71B |
| Terumo | 4,075.20B |
| Otsuka Holdings | 3,515.61B |
| Astellas Pharma | 2,473.03B |
| Olympus | 2,051.39B |